Expert Review of Pharmacoeconomics & Outcomes Research · 2009 · 393 citations · 48 references
Public AffairsHealth PolicyPharmacoeconomicsHealth EconomicsHealth Services ResearchHealthcare EconomicsDirect Medical CostsEconomic EvaluationHealth Care CostsHealthcare Cost AnalysisHealthcare-associated Infection PreventionHealthcare-associated InfectionsDirect Cost AnalysisDirect Cost AssessmentDisease Cost Of IllnessEconomic Burden Of DiseaseEconomic Burden Of IllnessInfectious Disease EconomicsMedical Cost AnalysisPay-for-performance Measurement
Annually, approximately 2 million patients suffer with healthcare-associated infections (HAIs) in the USA, and nearly 90,000 are estimated to die. The overall direct cost of HAIs to hospitals ranges from US$28 billion to 45 billion. While the range is wide, HAIs are clearly expensive. In addition, most HAIs are thought to be preventable; however, published guidelines are not congruent. Important policy changes include mandating hospitals to publically report HAI rates and a federal pay-for-performance measure that will no longer allow Medicare to pay more for patients with HAIs. Further rigorous economic evaluations of specific interventions, as well as on evaluations of the policies, are required.
48
Andrew Wall · British Journal of Healthcare Management · 2000 · 5.9K citations
Health Professions, Health Policy, Health Services Administration +8
Jane D. Siegel, Emily Rhinehart, Marguerite M. Jackson et al. · American Journal of Infection Control · 2007 · 3.5K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +16